TOP
Papers quoted in Institute for Scientific Information,
Philadelphia, USA, Web of Science

Radovi citirani u Institutu za naučnu informaciju,
Filadelfija, SAD,
naučna mreža

1.  Mujagic Z, Mujagic H
Importance of serum prolactin determination in metastatic breast cancer patients
CROATIAN MEDICAL JOURNAL 45 (2): 176-180 APR 2004
Times Cited: 5
Context Sensitive Links

2.  Mujagic Z, Mujagic H
Circulating levels of prolactin as an indicator of effectiveness of therapy in breast cancer patients
INTERNATIONAL JOURNAL OF CANCER : 216-216 Suppl. 13 2002
Times Cited:
0
Context Sensitive Links

3.  Mujagic H, Chabner BA, Mujagic Z
Mechanisms of action and potential therapeutic uses of thalidomide
CROATIAN MEDICAL JOURNAL 43 (3): 274-285 JUN 2002
Times Cited:
4
Context Sensitive Links

4.  MUJAGIC H, MUJAGIC Z
DETECTION OF PLEIOTROPIC DRUG-RESISTANCE BY THE RAPID IMMUNOFLUORESCENCE ASSAY OF DRUG EFFECTS ON THE CELL SKELETON
ONCOLOGY 48 (3): 202-209 MAY-JUN 1991
Times Cited:
4
Context Sensitive Links

5.  MUJAGIC H, KRNJAJIC N, JEVRIC A
THE LEVELS AND RELATIONS OF PROSTAGLANDINS IN PREGNANT AND NON-PREGNANT TUMOR-BEARING MICE
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 115 (4): 383-387 1989
Times Cited:
0
Context Sensitive Links View full text from the publisher

6.  MUJAGIC H, SHACKNEY SE, SMITH CE, et al.
QUANTITATIVE CHANGES IN SURFACE-IMMUNOGLOBULIN EXPRESSION IN WEHI-231 LYMPHOMA-CELLS IN RELATION TO THEIR PROLIFERATIVE RATE
ONCOLOGY 43 (4): 237-242 1986
Times Cited:
1
Context Sensitive Links

7.  MUJAGIC H, HAMEL E, CURT G, et al.
DETECTION OF PLEIOTROPIC DRUG-RESISTANCE (PDR) BY IMMUNOFLUORESCENT ASSAY OF DRUG EFFECTS ON CYTOSKELETON
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 26 (MAR): 338-338 1985
Times Cited: 0
Context Sensitive Links

8.  CURT GA, BAILEY BD, MUJAGIC H, et al.
PLEIOTROPIC DRUG-RESISTANCE (PDR) IN HUMAN MCF-7 BREAST-CANCER CELLS
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 25 (MAR): 337-337 1984
Times Cited:
1
Context Sensitive Links

9.  MALENICA B, MUJAGIC H, POPOVIC S, et al.
IMMUNOCOMPETENCE IN PATIENTS WITH MALIGNANT-MELANOMA
PERIODICUM BIOLOGORUM 85: 351-352 Suppl. 3 1983
Times Cited:
0
Context Sensitive Links

10.  MUJAGIC H, OCCHIPINTI S, SMITH C, et al.
QUANTITATIVE CHANGES IN SURFACE-IMMUNOGLOBULIN IN RELATION TO CELL-PROLIFERATION IN MURINE WEHI-231 B-CELL LYMPHOMA INVITRO
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 24 (MAR): 7-7 1983
Times Cited:
0
Context Sensitive Links

11.  MUJAGIC H, CHEN SS, GEIST R, et al.
EFFECTS OF VINCRISTINE ON CELL-SURVIVAL, CELL-CYCLE PROGRESSION, AND MITOTIC ACCUMULATION IN ASYNCHRONOUSLY GROWING SARCOMA 180-CELLS
CANCER RESEARCH 43 (8): 3591-3597 1983
Times Cited:
20
Context Sensitive Links

12.  MUJAGIC H, CONGER BM, SMITH CA, et al.
SCHEDULE DEPENDENCE OF VINCRISTINE LETHALITY IN SARCOMA 180 CELLS FOLLOWING PARTIAL SYNCHRONIZATION WITH HYDROXYUREA
CANCER RESEARCH 43 (8): 3598-3603 1983
Times Cited:
3
Context Sensitive Links

13.  CONGER B, OCCHIPINTI SJ, MUJAGIC H, et al.
STUDIES ON THE LETHAL AND SUBLETHAL EFFECTS OF VINCRISTINE (VCR) IN SARCOMA 180 INVITRO
CELL AND TISSUE KINETICS 15 (6): 674-674 1982
Times Cited:
0
Context Sensitive Links

14.  MUJAGIC H, SMITH CE, SCHUETTE WH, et al.
THE CELL TUBULIN CONTENT FREQUENCY HISTOGRAM OBTAINED BY FLOW-CYTOMETRY IN SARCOMA 180 CELLS-INVITRO
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 23 (MAR): 28-28 1982
Times Cited:
1
Context Sensitive Links

15.  MUJAGIC H
IMMUNOTHERAPY WITH BCG - AN ATTEMPT AT STANDARDIZATION OF METHODS BASED ON OUR EXPERIENCE AND RESULTS
PERIODICUM BIOLOGORUM 82 (2): 195-205 1980
Times Cited:
0
Context Sensitive Links

16.  MUJAGIC H, DESKOVIC M, MALENICA B, et al.
THE SIGNIFICANCE OF TUBERCULIN IMMUNITY TESTING IN CANCER-PATIENTS
CELLULAR AND MOLECULAR BIOLOGY 26 (2): 111-121 1980
Times Cited: 2
Context Sensitive Links

17.  MUJAGIC H, KOLARIC K, MALENICA B, et al.
BCG IMMUNOTHERAPY IN PREVIOUSLY TREATED MALIGNANT-MELANOMA PATIENTS
BIOMEDICINE 30 (2): 95-102 1979
Times Cited: 2
Context Sensitive Links

18.  MUJAGIC H, KRUSIC J, DESKOVIC M, et al.
IMMUNOLOGICAL REACTIVITY TO NONSPECIFIC ANTIGENS IN CERVICAL CARCINOMA PATIENTS
PERIODICUM BIOLOGORUM 78: 151-153 Suppl. 1 1976
Times Cited: 0
Context Sensitive Links

19.  MUJAGIC H, NOLA P, MALENICA B, et al.
IMMUNOLOGICAL REACTIVITY IN COLORECTAL CARCINOMA PATIENTS WITH SPECIAL REFERENCE TO NEW T-S CLASSIFICATION OF CARCINOMAS OF COLON AND RECTUM
PERIODICUM BIOLOGORUM 78: 153-154 Suppl. 1 1976
Times Cited: 1
Context Sensitive Links

20.ROGAN J, MUJAGIC H, MALENICA B
LYMPHOCYTE CYTOTOXICITY TO MALIGNANT-MELANOMA AND CERVICAL CARCINOMA CELLS
PERIODICUM BIOLOGORUM 78: 155-156 Suppl. 1 1976
Times Cited:
0
Context Sensitive Links

21.  MUJAGIC H, MAZURAN R, MALENICA B, et al.
CLINICAL DETECTION OF CELLULAR IMMUNITY INVITRO TO MELANOMA SPECIFIC ANTIGENS IN MAN BY MONOCYTE SPREADING INHIBITION TEST - CORRELATION BETWEEN INVIVO AND INVITRO IMMUNOLOGICAL TEST PARAMETERS
PERIODICUM BIOLOGORUM 78: 156-157 Suppl. 1 1976
Times Cited:
0
Context Sensitive Links

22.  MALENICA B, MUJAGIC H, KOLARIC K, et al.
BCG IMMUNOTHERAPY IN METASTATIC MALIGNANT-MELANOMA
PERIODICUM BIOLOGORUM 78: 158-158 Suppl. 1 1976
Times Cited: 0
Context Sensitive Links

23.  MAZURAN R, MUJAGIC H, MALENICA B, et al.
INVITRO DETECTION OF CELLULAR IMMUNITY TO MELANOMA ANTIGENS IN MAN BY MONOCYTE SPREADING INHIBITION TEST
INTERNATIONAL JOURNAL OF CANCER 17 (1): 14-20 1976
Times Cited:
14
Context Sensitive Links

24.  MILAS L, MUJAGIC H
EFFECT OF SPLENECTOMY ON FIBROSARCOMA METASTASES IN LUNGS OF MICE
INTERNATIONAL JOURNAL OF CANCER 11 (1): 186-190 1973
Times Cited:
43
Context Sensitive Links

25.  MILAS L, MUJAGIC H
PROTECTION BY CORYNEBACTERIUM PARVUM AGAINST TUMOR-CELLS INJECTED INTRAVENOUSLY
REVUE EUROPEENNE D ETUDES CLINIQUES ET BIOLOGIQUE 17 (5): 498& 1972
Times Cited:
3
Context Sensitive Links

Powered by ORBUS.ONE